Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

The global colloids (blood plasma) industry is mature. The production of Human Albumin increase from 544.08 MT in 2010 to 805.38 MT in 2015, with an average growth rate of more than 9.60 %. The production of synthetic colloids increase from 42.03 Million Units in 2010 to 53.43 Million Units in 2015, with an average growth rate of more than 5.42 %.

The production growth rate of hydroxyethyl starch colloid reduced obviously because Europe and USA banned the usage of HES solutions in patients with sepsis. At the same time, this stimulated the increase of growth rate in albumin colloids.

The manufacturers and consumers of natural colloids and synthetic colloids are both concentrated in North America, Europe and China. North America is the largest manufacturer and consumer in natural colloids , however Europe occupies the largest share in the global synthetic market.

According to this study, over the next five years the Colloids (Blood Plasma) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Colloids (Blood Plasma) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Colloids (Blood Plasma) market by product type, application, key manufacturers and key regions and countries.

This study considers the Colloids (Blood Plasma) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Natural Type Colloids (Blood Plasma)

Synthetic Type Colloids (Blood Plasma)

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Extensive Burns

Massive Blood or Plasma Loss

Hypovolemic Shock

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

CSL Behring

Baxter

Grifols

Octapharma

Kedrion

Shanghai Raas

CTBB

Hualan Bio

Rongsheng Pharmaceutical

Boya Rongsheng

B. Braun Medical

Fresenius Kabi

HOSPIRA

Axa parenterals

Fresenius Kabi(China)

CR Double-Crane

Kelun Group

Shandong Qidu Pharmaceutical

Shandong Hualu Pharmaceutical

Minsheng Pharma

Kanglepharm

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Colloids (Blood Plasma) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Colloids (Blood Plasma) market by identifying its various subsegments.

Focuses on the key global Colloids (Blood Plasma) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Colloids (Blood Plasma) with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Colloids (Blood Plasma) submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Colloids (Blood Plasma) Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Colloids (Blood Plasma) Consumption 2014-2024

2.1.2 Colloids (Blood Plasma) Consumption CAGR by Region

2.2 Colloids (Blood Plasma) Segment by Type

2.2.1 Natural Type Colloids (Blood Plasma)

2.2.2 Synthetic Type Colloids (Blood Plasma)

2.3 Colloids (Blood Plasma) Consumption by Type

2.3.1 Global Colloids (Blood Plasma) Consumption Market Share by Type (2014-2019)

2.3.2 Global Colloids (Blood Plasma) Revenue and Market Share by Type (2014-2019)

2.3.3 Global Colloids (Blood Plasma) Sale Price by Type (2014-2019)

2.4 Colloids (Blood Plasma) Segment by Application

2.4.1 Extensive Burns

2.4.2 Massive Blood or Plasma Loss

2.4.3 Hypovolemic Shock

2.4.4 Others

2.5 Colloids (Blood Plasma) Consumption by Application

2.5.1 Global Colloids (Blood Plasma) Consumption Market Share by Application (2014-2019)

2.5.2 Global Colloids (Blood Plasma) Value and Market Share by Application (2014-2019)

2.5.3 Global Colloids (Blood Plasma) Sale Price by Application (2014-2019)

3 Global Colloids (Blood Plasma) by Players

3.1 Global Colloids (Blood Plasma) Sales Market Share by Players

3.1.1 Global Colloids (Blood Plasma) Sales by Players (2017-2019)

3.1.2 Global Colloids (Blood Plasma) Sales Market Share by Players (2017-2019)

3.2 Global Colloids (Blood Plasma) Revenue Market Share by Players

3.2.1 Global Colloids (Blood Plasma) Revenue by Players (2017-2019)

3.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Players (2017-2019)

3.3 Global Colloids (Blood Plasma) Sale Price by Players

3.4 Global Colloids (Blood Plasma) Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Colloids (Blood Plasma) Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Colloids (Blood Plasma) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Colloids (Blood Plasma) by Regions

4.1 Colloids (Blood Plasma) by Regions

4.1.1 Global Colloids (Blood Plasma) Consumption by Regions

4.1.2 Global Colloids (Blood Plasma) Value by Regions

4.2 Americas Colloids (Blood Plasma) Consumption Growth

4.3 APAC Colloids (Blood Plasma) Consumption Growth

4.4 Europe Colloids (Blood Plasma) Consumption Growth

4.5 Middle East & Africa Colloids (Blood Plasma) Consumption Growth

5 Americas

5.1 Americas Colloids (Blood Plasma) Consumption by Countries

5.1.1 Americas Colloids (Blood Plasma) Consumption by Countries (2014-2019)

5.1.2 Americas Colloids (Blood Plasma) Value by Countries (2014-2019)

5.2 Americas Colloids (Blood Plasma) Consumption by Type

5.3 Americas Colloids (Blood Plasma) Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Colloids (Blood Plasma) Consumption by Countries

6.1.1 APAC Colloids (Blood Plasma) Consumption by Countries (2014-2019)

6.1.2 APAC Colloids (Blood Plasma) Value by Countries (2014-2019)

6.2 APAC Colloids (Blood Plasma) Consumption by Type

6.3 APAC Colloids (Blood Plasma) Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Colloids (Blood Plasma) by Countries

7.1.1 Europe Colloids (Blood Plasma) Consumption by Countries (2014-2019)

7.1.2 Europe Colloids (Blood Plasma) Value by Countries (2014-2019)

7.2 Europe Colloids (Blood Plasma) Consumption by Type

7.3 Europe Colloids (Blood Plasma) Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Colloids (Blood Plasma) by Countries

8.1.1 Middle East & Africa Colloids (Blood Plasma) Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Colloids (Blood Plasma) Value by Countries (2014-2019)

8.2 Middle East & Africa Colloids (Blood Plasma) Consumption by Type

8.3 Middle East & Africa Colloids (Blood Plasma) Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Colloids (Blood Plasma) Distributors

10.3 Colloids (Blood Plasma) Customer

11 Global Colloids (Blood Plasma) Market Forecast

11.1 Global Colloids (Blood Plasma) Consumption Forecast (2019-2024)

11.2 Global Colloids (Blood Plasma) Forecast by Regions

11.2.1 Global Colloids (Blood Plasma) Forecast by Regions (2019-2024)

11.2.2 Global Colloids (Blood Plasma) Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Colloids (Blood Plasma) Forecast by Type

11.8 Global Colloids (Blood Plasma) Forecast by Application

12 Key Players Analysis

12.1 CSL Behring

12.1.1 Company Details

12.1.2 Colloids (Blood Plasma) Product Offered

12.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 CSL Behring News

12.2 Baxter

12.2.1 Company Details

12.2.2 Colloids (Blood Plasma) Product Offered

12.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Baxter News

12.3 Grifols

12.3.1 Company Details

12.3.2 Colloids (Blood Plasma) Product Offered

12.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Grifols News

12.4 Octapharma

12.4.1 Company Details

12.4.2 Colloids (Blood Plasma) Product Offered

12.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Octapharma News

12.5 Kedrion

12.5.1 Company Details

12.5.2 Colloids (Blood Plasma) Product Offered

12.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Kedrion News

12.6 Shanghai Raas

12.6.1 Company Details

12.6.2 Colloids (Blood Plasma) Product Offered

12.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Shanghai Raas News

12.7 CTBB

12.7.1 Company Details

12.7.2 Colloids (Blood Plasma) Product Offered

12.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 CTBB News

12.8 Hualan Bio

12.8.1 Company Details

12.8.2 Colloids (Blood Plasma) Product Offered

12.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 Hualan Bio News

12.9 Rongsheng Pharmaceutical

12.9.1 Company Details

12.9.2 Colloids (Blood Plasma) Product Offered

12.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 Rongsheng Pharmaceutical News

12.10 Boya Rongsheng

12.10.1 Company Details

12.10.2 Colloids (Blood Plasma) Product Offered

12.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 Boya Rongsheng News

12.11 B. Braun Medical

12.12 Fresenius Kabi

12.13 HOSPIRA

12.14 Axa parenterals

12.15 Fresenius Kabi(China)

12.16 CR Double-Crane

12.17 Kelun Group

12.18 Shandong Qidu Pharmaceutical

12.19 Shandong Hualu Pharmaceutical

12.20 Minsheng Pharma

12.21 Kanglepharm

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Colloids (Blood Plasma)

Table Product Specifications of Colloids (Blood Plasma)

Figure Colloids (Blood Plasma) Report Years Considered

<